Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic

The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Killelea, Amy, Johnson, Jeremiah, Dangerfield, Derek T., Beyrer, Chris, McGough, Matthew, McIntyre, John, Gee, Rebekah E., Ballreich, Jeromie, Conti, Rena, Horn, Tim, Pickett, Jim, Sharfstein, Joshua M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Policy Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341207/
https://www.ncbi.nlm.nih.gov/pubmed/35902089
http://dx.doi.org/10.1017/jme.2022.30
Descripción
Sumario:The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and delivery system to unlock broad access to PrEP for those most vulnerable to HIV acquisition and bring an end to the HIV epidemic.

Ejemplares similares